Who owns Armata Pharmaceuticals Inc?
- Ticker: ARMP
- CUSIP Number: 04216r102
Tip: Access positions for across all investors
Analyze quarterly positions in Armata Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Armata Pharmaceuticals stock
Who bought or sold Armata Pharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Bank of America Corporation | 635k | $2.1M | 0% | Dec 2023 |
|
| Vanguard Group | 145k | $470k | 59% | Dec 2023 |
|
| SeaCrest Wealth Management | 33k | $137k | 81% | Mar 2024 |
|
| Captrust Financial Advisors | 14k | $44k | 0% | Dec 2023 |
|
| Larson Financial Group | 967.00 | $3.1k | 100% | Dec 2023 |
|
| Trifecta Capital Advisors | 714.00 | $3.0k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 282.00 | $1.0k | 1467% | Dec 2023 |
|
| Householder Group Estate & Retirement Specialist | 136.00 | $0 | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 105.00 | $340.000500 | 100% | Dec 2023 |
|
| Salem Investment Counselors | 100.00 | $418.000000 | 0% | Mar 2024 |
|
| Wells Fargo & Company | 84.00 | $272.244000 | 5% | Dec 2023 |
|
| Team Financial Group | 71.00 | $229.997400 | 0% | Dec 2023 |
|
| UBS Group | 1.00 | $3.000000 | -100% | Dec 2023 |
|
Who sold out of Armata Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Dimensional Fund Advisors | Sep 2023 | 12k | $34k |
| Tennessee Valley Asset Management Partners | Dec 2023 | 279.00 | $903.987900 |